China in Vitro Diagnostics Market, Size, Forecast 2022-2027

China In-vitro diagnostics (IVD) Market is central to the provision of healthcare globally and is estimated to be US$ 18.9 Billion in 2027. Besides, China is the largest clinical laboratory market in Asia and one of the world's fastest-growing medical realms. Remarkably, over the past years, the rate of Chinese economic growth has been impressive, setting lucrative growth in GDP per year. In addition, the Chinese IVD landscape has historically been controlled by large international providers, with few domestic instrumentation and assay suppliers. Further, looking for a change, the start-up company sees the evolution of diagnostic platforms and assays presenting rapid detection for a wide range of blood-based markers.

Leave a Reply